

Mammogram
“A 25 year Canadian study just published in the British Medical Journal questions the value of mammography. Research suggesting that mammography may not be beneficial was covered by some of the nation’s most widely-read newspapers as well as on several medical websites.
“In a front-page story, the New York Times (2/12, Kolata) reports that research published in the BMJ, “one of the largest and most meticulous studies of mammography ever done, involving 90,000 women and lasting a quarter-century, has added powerful new doubts about the value of the screening test for women of any age.”
“The findings may “lead to an even deeper polarization between those who believe that regular mammography saves lives, including many breast cancer patients and advocates for them, and a growing number of researchers who say the evidence is lacking or, at the very least, murky.”
“The Los Angeles Times (2/12, Morin) reports that investigators “examined the medical records of 89,835 women in six Canadian provinces between the ages of 40 and 59. All of the trial participants received annual physical breast examinations, while half of them also had yearly mammogram screenings for five years, beginning in 1980.” During “the next 25 years, 3,250 of the 44,925 women in the mammography arm of the study were diagnosed with breast cancer, along with 3,133 of the 44,910 women in the control group.” Meanwhile, a nearly identical number of patients from each group died of breast cancer.
“In a separate story, the New York Times (2/12, Rabin) reports that the new findings will add to the controversy surrounding the value of mammograms. Further complicating the issue is the fact that different medical groups have different recommendations regarding mammography.
“USA Today (2/11, Szabo) reports that ‘Barbara Monsees, a radiologist with the American College of Radiology, says the…study is fundamentally flawed and useless for drawing conclusions.’ “
Blogfinger Medical Commentary by Paul Goldfinger MD, FACC:
If you walk on Main Avenue in Ocean Grove, if the snow has been cleared, you will see remnants of a pink stripe that was put down during a one month breast cancer fundraiser in October. The pink symbols were everywhere, and the theme was to promote mammograms for women who hadn’t had them. I thought that the pervasive drumbeat was overdone, given that it was all about pushing mammograms. I couldn’t recall another comparable fundraiser that focused on a diagnostic test rather than basic or clinical research into prevention and cures, so this month- long effort seemed to me to be out of proportion.
In 2009, the US Preventive Services Task Force recommended cutting back on mammograms for all women, and especially avoiding them altogether for those in their 40’s. They suggested that women age 50-74 have the test every other year. The American Cancer Society disagreed and suggested mammograms yearly from age 40 and up.
A controversy ensued which is still simmering and has now been exacerbated by this massive Canadian trial on nearly 90,000 women over 25 years. The study concluded that annual screening mammograms do not reduce death rates when compared to skilled manual examinations by specially trained nurses. They say that too many mammograms are being done and that mammograms can cause “harm.”
Last week, on NPR.org radio, there was a one hour discussion with Diane Rehm interviewing two of the world’s experts in mammography as they debated the results of the Canadian trial. They had practically opposite opinions and they were attacking each other over facts and even issues such as conflicts of interest and flawed conclusions.
So there is no way that I can do this subject justice except to summarize the facts and the issues, especially as put forth by the Canadian trial. I suggest that women do some reading on their own to avoid being swayed by experts with agendas:
1. Mammography is an imperfect test for the diagnosis of breast cancer and is over-rated as a life-saving procedure. The idea that early detection saves lives is being seriously questioned.
It is true that in recent years, the survival rates of breast cancer have improved significantly, especially in the 40-49 year old group, but the benefit seems to be due to newer treatment options, such as the drug tamoxifen, and not due to screening mammograms.
2. This huge Canadian trial is being criticized by some, such as a leading professor of radiology from Harvard, on the grounds that the study design was flawed, the quality of the mammograms was awful, and too many small tumors were missed due to antiquated machines. He also had other highly technical criticisms as well.
3. Even current mammography machines sometimes miss small cancers. The test also often raises questions about abnormalities that are not cancer (i.e. false positive results.) 30% of the time patients are brought back for more films causing great stress and extra radiation. In addition, the test may detect cancers that either are too small and slow growing to cause harm or are pre-cancerous conditions which will not endanger lives. One in five cancers found by mammography are the kind that pose no lethal threat, so those patients currently get unnecessary treatment.
4. The problem with such “over diagnosis” is that some women get subjected to harmful aggressive approaches including biopsies, drugs and mastectomies which are not necessary. The harms include drug toxicity, surgical mutilation and risks, and mental distress. The researchers in Canada say that sometimes mammograms cause more harm than good.
The clinical challenge is to decide which cancers can be left alone or just treated medically. The ability of oncologists to make these differentiations are currently inadequate.
5. Some fund raising organizations have been accused of over stressing the importance of mammography and distorting the statistics of success attributed to the test. (see the Time article below).
6. This new trial of 90,000 will cause all doctors who treat breast cancer to re-evaluate their use of mammography and will result in a new assessment of the criteria for ordering screening mammograms. These new guidelines should be available in 2015, but as with the PSA controversy, different expert panels will offer different recommendations.
7. At this time, most women will probably plan to continue with the same yearly regimen from age 40-59 (which is the age range of the new study,) but they may be surprised to find a more nuanced individualized approach when they see their doctors. And they may discover that their doctor offers them an option of skipping mammography altogether.
One potential concern is whether the new Obamacare insurance policies will cover all mammograms that are requested. This Canadian study will likely provoke women’s advocacy groups to object strenuously because most American women have been sold on the life-saving benefits of early diagnosis with mammography.
8. There will be many women who have not had mammography or who have been skeptical of the test. They will use the controversy as a reason not to have mammograms. But if a woman makes that choice, she must do self examinations and have a manual exam by an expert examiner yearly. (The same is true also for women who do have mammograms.) She also should discuss her decision with a doctor, because some individuals have higher risks than others.
9. New imaging methods are in the works including 3-D mammography.
Time magazine article on Komen ad
10. Here’s a link to a NY Times article on self examination of breasts:
self exam link
00
Read Full Post »